RAD News Alert Rite Aid Corp (RAD) 7.52 01/01/2015 15:39:23

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rite Aid Corp (RAD) 7.52 $RAD

Most active New York Stock Exchange-traded stocks
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
T: 33.59 (-0.49), GE: 25.27 (-0.30), F: 15.50 (unch), K.TO: 3.26 (+0.01), S: 4.15 (+0.03), KGC: 2.82 (+0.02), PFE: 31.15 (-0.23), BAC: 17.89 (-0.24), TWTR: 35.87 (+0.01), RAD: 7.52 (-0.04)

Rite Aid (RAD) Looks Promising; Have You Invested in It Yet? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 3:25PM CST
Rite Aid Corp. (RAD) is scoring high on the favorability radar, backed by a splendid stock performance all through 2014, having witnessed 49.4% growth year to date.
NPD: 1.58 (-0.10), CVS: 96.31 (-1.22), WMT: 85.88 (-0.91), RAD: 7.52 (-0.04)

Is Rite Aid's Rebound Done for Good?
Dan Caplinger, The Motley Fool - Motley Fool - Wed Dec 31, 2:02PM CST
Can Rite Aid make good on its future hopes? Image source: Rite Aid. For years, shares of drugstore-chain Rite Aid languished, as many doubted whether the company would ever be able to emerge from its extensive debt and stem its tide of losses....
RAD: 7.52 (-0.04)

Rite Aid, Nokia and Sirius XM, 3 Stocks Under $10 to Buy in 2015
at The Street - Wed Dec 31, 1:28PM CST
Investors looking for growth and value may find it in Rite Aid, Nokia and Sirius XM -- stocks trading under $10.
CVS: 96.31 (-1.22), MSFT: 46.45 (-0.57), WAG: 76.05 (-0.49), SIRI: 3.50 (-0.01), NOK: 7.86 (-0.09), RAD: 7.52 (-0.04)

Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor
at The Street - Tue Dec 30, 6:00PM CST
Cramer's first rule: Diversification is the only way to invest.
DUK: 83.54 (-1.16), SVU: 9.70 (-0.08), FB: 78.02 (-1.20), SKT: 36.96 (-0.69), ED: 66.01 (-0.90), FRT: 133.46 (-2.88), RSH: 0.37 (-0.02), PLKI: 56.27 (+0.29), CELG: 111.86 (-1.68), RAD: 7.52 (-0.04), T: 33.59 (-0.49), S: 4.15 (+0.03), CMG: 684.51 (-0.40), GLD: 113.58 (-1.62), GOOGL: 530.66 (-4.62), VZ: 46.78 (-0.55), AAPL: 110.38 (-2.14), REGN: 410.25 (+1.91)

Rite Aid Up 34.0% Since SmarTrend Uptrend Call (RAD)
Comtex SmarTrend(R) - Tue Dec 30, 9:48AM CST
SmarTrend identified an Uptrend for Rite Aid (NYSE:RAD) on December 8th, 2014 at $5.67. In approximately 3 weeks, Rite Aid has returned 33.95% as of today's recent price of $7.60.
RAD: 7.52 (-0.04)

Rite Aid Offers Exciting Rewards to Wish Customers a 'Happy You Year'
Business Wire - Mon Dec 29, 8:27AM CST
Rite Aid is ringing in the New Year by offering wellness+ members the opportunity to receive lifestyle and entertainment rewards for every $50 spent in stores on participating products now through January 24.
RAD: 7.52 (-0.04)

One Reason Rite Aid Could Soar Higher
Daniel Jones - at Seeking Alpha - Sun Dec 28, 3:39PM CST

RAD: 7.52 (-0.04)

3 Can't Miss Quotes from Rite Aid Corporation's CEO
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 28, 9:57AM CST
Source: Rite Aid Corp. Rite Aid Corporation   went from stock market darling to dud this past year, but solid fiscal third quarter results suggest that shares could return to their winning ways. Despite operating 23 fewer stores during the...
MCK: 207.58 (-2.03), CVS: 96.31 (-1.22), WAG: 76.05 (-0.49), RAD: 7.52 (-0.04)

SmarTrend Watching for Potential Pullback in Shares of Rite Aid After 2.07% Gain
Comtex SmarTrend(R) - Fri Dec 26, 3:49PM CST
Rite Aid (NYSE:RAD) traded in a range yesterday that spanned from a low of $7.26 to a high of $7.49. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $7.45 on volume of 19.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RAD: 7.52 (-0.04)

5 Things Rite Aid Corporation's Management Wants You to Know
Keith Speights, The Motley Fool - Motley Fool - Fri Dec 26, 10:02AM CST
Shareholders of Rite Aid Corporation weren't feeling too great after the company's second-quarter results . Shares dropped more than 18% on the day of the pharmacy retailer's earnings release because of gloominess about the rest of the year. But...
MCK: 207.58 (-2.03), RAD: 7.52 (-0.04)

Rite Aid On Track As Is Evident From Healthy Expected Growth Rate
Equity Watch - Seeking Alpha - Thu Dec 25, 1:52AM CST
A growing and aging U.S. population and healthcare expenditures will positively affect U.S. drug retailers in the future. As far as Rite Aid (NYSE: RAD ) is concerned, due to its strong strategic alliance with RediClinic, along with rapid remodeling...
RAD: 7.52 (-0.04)

Rite Aid: Still Some Upside Even After Price Increase
Musings of a Banker - at Seeking Alpha - Thu Dec 25, 12:28AM CST

RAD: 7.52 (-0.04)

Can Rite Aid (RAD) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 7:46AM CST
Rite Aid has decent short-term momentum and it is seeing solid activity on the earnings estimate revision front as well
RAD: 7.52 (-0.04)

Rite Aid: Patience Is Sweet
Jeffrey Himelson - at Seeking Alpha - Wed Dec 24, 2:55AM CST

RAD: 7.52 (-0.04)

Walgreen Company Delivers a Prescription for Growth
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 9:39PM CST
Source: Walgreen. Walgreen Company is the nation's biggest pharmacy store operator, with more than 8,200 stores, but it's also becoming a major global drug retailer thanks to its merger with Alliance Boots, which should be completed at the end...
WAG: 76.05 (-0.49), RAD: 7.52 (-0.04)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 84

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Patriot Fund Gala Celebrates Veterans and America's 250th

Updated Category News Views 44

Celebrating Service and Patriotism in Philadelphia The Patriot Fund is gearing up for its 11th Annual Gala, a night dedicated to honoring the veterans who have sacrificed so much for this nation. Set against the historic backdrop of Philadelphia, the gala coincides with America's 250th anniversary—couldn't have picked a better time or place for such an event. It’s not...

Continue Reading
Netcapital's Revenue Fraud Scandal Hits Investor Confidence

Updated Category News Views 60

The Rise and Fall of Netcapital: A Troubling Drop Netcapital Inc. (NASDAQ: NCPL) has found itself in hot water with investors after revelations of a wild scheme to fluff up its revenue figures. It’s like watching a house of cards crumble — and investors are left holding the bag. From December 15, 2021, through September 3, 2026, a slew of misinformation allegedly...

Continue Reading
Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 0

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Medline's MedTrans Rodeo: Honoring Driver Excellence

Updated Category News Views 72

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 49

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading
Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Updated Category News Views 6

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

MacroGenics, Inc. Investors Urged for Legal Deadlines Awareness

Updated Category News Views 83

Attention MacroGenics Investors MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company dedicated to creating and selling innovative treatments, is currently facing an ongoing securities class action lawsuit. If you own or have owned shares of MacroGenics within a certain timeframe, it's important to be aware of this situation, as it may significantly affect your...

Continue Reading
Analyzing Micron Technology's Stock Performance Amid Challenges

Updated Category News Views 143

Micron Technology's Recent Stock Struggles In recent weeks, Micron Technology Inc. has encountered significant hurdles, causing its stock price to fall sharply. The manufacturer of computer memory chips continues to experience an extended selloff, heavily influenced by analysts expressing concerns about its standing in the artificial intelligence market. Impact of Analyst...

Continue Reading
Peter Schiff Critiques Government Spending on Cryptocurrency

Updated Category News Views 86

Peter Schiff's Critique on Government Cryptocurrency Investments Bitcoin critic Peter Schiff has recently expressed strong opinions against the government's foray into cryptocurrency, labeling these investments as a significant misallocation of public resources. Schiff's viewpoint is clear: countries that actively engage in holding digital assets are likely to end up as...

Continue Reading
Concerns Grow Among British Businesses Over New Regulations

Updated Category News Views 158

Concerns from British Businesses About Employment Regulations Many British businesses are voicing serious concerns about the new employment regulations proposed by the recently elected Labour government. Their anxiety primarily arises from the fear that enhanced protections for employees might complicate the hiring process, as emphasized by the Confederation of British...

Continue Reading
Faruqi & Faruqi Investigates Investors' Claims on STZ

Updated Category News Views 176

Faruqi & Faruqi Investigates Claims for Investors Faruqi & Faruqi, LLP is a prominent national securities law firm that is currently examining possible claims related to Constellation Brands, Inc. (NYSE: STZ). The firm invites investors who may have experienced losses exceeding $50,000 in Constellation Brands to reach out for professional guidance and support. Legal...

Continue Reading